Article By:
Retail Investor 360
Sunday, September 14, 2014 3:42 PM EDT
Since the FDA approved Ferric Citrate, KERX's share price went up 28%. Wall Street analysts, however, are concerned about the drug's warning label of iron overload. But do doctors share that same concern?
In this article: KERX